0001417398--09-302022Q2FALSE75.875.872.472.73.43.10.21750.21500.43500.43006.0P6MP3Y3400,00000014173982021-10-012022-03-3100014173982022-05-04xbrli:shares00014173982022-01-012022-03-31iso4217:USD00014173982021-01-012021-03-3100014173982020-10-012021-03-31iso4217:USDxbrli:shares00014173982022-03-3100014173982021-09-3000014173982020-03-302020-03-3000014173982020-09-3000014173982021-03-310001417398us-gaap:CommonStockMember2021-12-310001417398us-gaap:AdditionalPaidInCapitalMember2021-12-310001417398us-gaap:RetainedEarningsMember2021-12-310001417398us-gaap:TreasuryStockMember2021-12-310001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001417398us-gaap:NoncontrollingInterestMember2021-12-3100014173982021-12-310001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001417398us-gaap:NoncontrollingInterestMember2022-01-012022-03-310001417398us-gaap:RetainedEarningsMember2022-01-012022-03-310001417398us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001417398us-gaap:TreasuryStockMember2022-01-012022-03-310001417398us-gaap:CommonStockMember2022-03-310001417398us-gaap:AdditionalPaidInCapitalMember2022-03-310001417398us-gaap:RetainedEarningsMember2022-03-310001417398us-gaap:TreasuryStockMember2022-03-310001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-03-310001417398us-gaap:NoncontrollingInterestMember2022-03-310001417398us-gaap:CommonStockMember2021-09-300001417398us-gaap:AdditionalPaidInCapitalMember2021-09-300001417398us-gaap:RetainedEarningsMember2021-09-300001417398us-gaap:TreasuryStockMember2021-09-300001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-300001417398us-gaap:NoncontrollingInterestMember2021-09-300001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-10-012022-03-310001417398us-gaap:NoncontrollingInterestMember2021-10-012022-03-310001417398us-gaap:RetainedEarningsMember2021-10-012022-03-310001417398us-gaap:AdditionalPaidInCapitalMember2021-10-012022-03-310001417398us-gaap:TreasuryStockMember2021-10-012022-03-310001417398us-gaap:CommonStockMember2020-12-310001417398us-gaap:AdditionalPaidInCapitalMember2020-12-310001417398us-gaap:RetainedEarningsMember2020-12-310001417398us-gaap:TreasuryStockMember2020-12-310001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-310001417398us-gaap:NoncontrollingInterestMember2020-12-3100014173982020-12-310001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001417398us-gaap:NoncontrollingInterestMember2021-01-012021-03-310001417398us-gaap:RetainedEarningsMember2021-01-012021-03-310001417398us-gaap:AdditionalPaidInCapitalMember2021-01-012021-03-310001417398us-gaap:TreasuryStockMember2021-01-012021-03-310001417398us-gaap:CommonStockMember2021-03-310001417398us-gaap:AdditionalPaidInCapitalMember2021-03-310001417398us-gaap:RetainedEarningsMember2021-03-310001417398us-gaap:TreasuryStockMember2021-03-310001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-03-310001417398us-gaap:NoncontrollingInterestMember2021-03-310001417398us-gaap:CommonStockMember2020-09-300001417398us-gaap:AdditionalPaidInCapitalMember2020-09-300001417398us-gaap:RetainedEarningsMember2020-09-300001417398us-gaap:TreasuryStockMember2020-09-300001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-09-300001417398us-gaap:NoncontrollingInterestMember2020-09-300001417398us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-10-012021-03-310001417398us-gaap:NoncontrollingInterestMember2020-10-012021-03-310001417398us-gaap:RetainedEarningsMember2020-10-012021-03-310001417398us-gaap:AdditionalPaidInCapitalMember2020-10-012021-03-310001417398us-gaap:TreasuryStockMember2020-10-012021-03-31hi:segmentxbrli:pure0001417398srt:CumulativeEffectPeriodOfAdoptionAdjustmentMemberus-gaap:AccountingStandardsUpdate201802Memberus-gaap:RetainedEarningsMember2019-10-0100014173982021-04-012022-03-310001417398hi:PlasticsMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:PlasticsMemberhi:MilacronMember2022-01-012022-03-310001417398hi:PlasticsMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:PlasticsMember2022-01-012022-03-310001417398hi:PlasticsMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:PlasticsMemberhi:MilacronMember2021-10-012022-03-310001417398hi:PlasticsMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:PlasticsMember2021-10-012022-03-310001417398hi:ProcessEquipmentGroupMemberhi:AutomotiveMember2022-01-012022-03-310001417398hi:MilacronMemberhi:AutomotiveMember2022-01-012022-03-310001417398hi:BatesvilleSegmentMemberhi:AutomotiveMember2022-01-012022-03-310001417398hi:AutomotiveMember2022-01-012022-03-310001417398hi:ProcessEquipmentGroupMemberhi:AutomotiveMember2021-10-012022-03-310001417398hi:MilacronMemberhi:AutomotiveMember2021-10-012022-03-310001417398hi:BatesvilleSegmentMemberhi:AutomotiveMember2021-10-012022-03-310001417398hi:AutomotiveMember2021-10-012022-03-310001417398hi:ChemicalsMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:ChemicalsMemberhi:MilacronMember2022-01-012022-03-310001417398hi:ChemicalsMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:ChemicalsMember2022-01-012022-03-310001417398hi:ChemicalsMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:ChemicalsMemberhi:MilacronMember2021-10-012022-03-310001417398hi:ChemicalsMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:ChemicalsMember2021-10-012022-03-310001417398hi:ConsumerGoodsMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:ConsumerGoodsMemberhi:MilacronMember2022-01-012022-03-310001417398hi:ConsumerGoodsMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:ConsumerGoodsMember2022-01-012022-03-310001417398hi:ConsumerGoodsMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:ConsumerGoodsMemberhi:MilacronMember2021-10-012022-03-310001417398hi:ConsumerGoodsMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:ConsumerGoodsMember2021-10-012022-03-310001417398hi:FoodPharmaceuticalsMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:FoodPharmaceuticalsMemberhi:MilacronMember2022-01-012022-03-310001417398hi:FoodPharmaceuticalsMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:FoodPharmaceuticalsMember2022-01-012022-03-310001417398hi:FoodPharmaceuticalsMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:FoodPharmaceuticalsMemberhi:MilacronMember2021-10-012022-03-310001417398hi:FoodPharmaceuticalsMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:FoodPharmaceuticalsMember2021-10-012022-03-310001417398hi:ProcessEquipmentGroupMemberhi:CustomMoldersMember2022-01-012022-03-310001417398hi:MilacronMemberhi:CustomMoldersMember2022-01-012022-03-310001417398hi:BatesvilleSegmentMemberhi:CustomMoldersMember2022-01-012022-03-310001417398hi:CustomMoldersMember2022-01-012022-03-310001417398hi:ProcessEquipmentGroupMemberhi:CustomMoldersMember2021-10-012022-03-310001417398hi:MilacronMemberhi:CustomMoldersMember2021-10-012022-03-310001417398hi:BatesvilleSegmentMemberhi:CustomMoldersMember2021-10-012022-03-310001417398hi:CustomMoldersMember2021-10-012022-03-310001417398us-gaap:ConstructionMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398us-gaap:ConstructionMemberhi:MilacronMember2022-01-012022-03-310001417398us-gaap:ConstructionMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398us-gaap:ConstructionMember2022-01-012022-03-310001417398us-gaap:ConstructionMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398us-gaap:ConstructionMemberhi:MilacronMember2021-10-012022-03-310001417398us-gaap:ConstructionMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398us-gaap:ConstructionMember2021-10-012022-03-310001417398hi:PackagingMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:PackagingMemberhi:MilacronMember2022-01-012022-03-310001417398hi:PackagingMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:PackagingMember2022-01-012022-03-310001417398hi:PackagingMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:PackagingMemberhi:MilacronMember2021-10-012022-03-310001417398hi:PackagingMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:PackagingMember2021-10-012022-03-310001417398hi:MineralsMiningMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:MineralsMiningMemberhi:MilacronMember2022-01-012022-03-310001417398hi:MineralsMiningMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:MineralsMiningMember2022-01-012022-03-310001417398hi:MineralsMiningMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:MineralsMiningMemberhi:MilacronMember2021-10-012022-03-310001417398hi:MineralsMiningMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:MineralsMiningMember2021-10-012022-03-310001417398hi:ElectronicsMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:ElectronicsMemberhi:MilacronMember2022-01-012022-03-310001417398hi:ElectronicsMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:ElectronicsMember2022-01-012022-03-310001417398hi:ElectronicsMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:ElectronicsMemberhi:MilacronMember2021-10-012022-03-310001417398hi:ElectronicsMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:ElectronicsMember2021-10-012022-03-310001417398hi:MedicalMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:MedicalMemberhi:MilacronMember2022-01-012022-03-310001417398hi:MedicalMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:MedicalMember2022-01-012022-03-310001417398hi:MedicalMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:MedicalMemberhi:MilacronMember2021-10-012022-03-310001417398hi:MedicalMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:MedicalMember2021-10-012022-03-310001417398hi:DeathCareMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:DeathCareMemberhi:MilacronMember2022-01-012022-03-310001417398hi:DeathCareMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:DeathCareMember2022-01-012022-03-310001417398hi:DeathCareMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:DeathCareMemberhi:MilacronMember2021-10-012022-03-310001417398hi:DeathCareMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:DeathCareMember2021-10-012022-03-310001417398hi:OtherEndMarketsMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:OtherEndMarketsMemberhi:MilacronMember2022-01-012022-03-310001417398hi:OtherEndMarketsMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:OtherEndMarketsMember2022-01-012022-03-310001417398hi:OtherEndMarketsMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:OtherEndMarketsMemberhi:MilacronMember2021-10-012022-03-310001417398hi:OtherEndMarketsMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:OtherEndMarketsMember2021-10-012022-03-310001417398hi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:MilacronMember2022-01-012022-03-310001417398hi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:MilacronMember2021-10-012022-03-310001417398hi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:PlasticsMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:PlasticsMemberhi:MilacronMember2021-01-012021-03-310001417398hi:PlasticsMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:PlasticsMember2021-01-012021-03-310001417398hi:PlasticsMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:PlasticsMemberhi:MilacronMember2020-10-012021-03-310001417398hi:PlasticsMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:PlasticsMember2020-10-012021-03-310001417398hi:ProcessEquipmentGroupMemberhi:AutomotiveMember2021-01-012021-03-310001417398hi:MilacronMemberhi:AutomotiveMember2021-01-012021-03-310001417398hi:BatesvilleSegmentMemberhi:AutomotiveMember2021-01-012021-03-310001417398hi:AutomotiveMember2021-01-012021-03-310001417398hi:ProcessEquipmentGroupMemberhi:AutomotiveMember2020-10-012021-03-310001417398hi:MilacronMemberhi:AutomotiveMember2020-10-012021-03-310001417398hi:BatesvilleSegmentMemberhi:AutomotiveMember2020-10-012021-03-310001417398hi:AutomotiveMember2020-10-012021-03-310001417398hi:ChemicalsMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:ChemicalsMemberhi:MilacronMember2021-01-012021-03-310001417398hi:ChemicalsMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:ChemicalsMember2021-01-012021-03-310001417398hi:ChemicalsMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:ChemicalsMemberhi:MilacronMember2020-10-012021-03-310001417398hi:ChemicalsMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:ChemicalsMember2020-10-012021-03-310001417398hi:ConsumerGoodsMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:ConsumerGoodsMemberhi:MilacronMember2021-01-012021-03-310001417398hi:ConsumerGoodsMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:ConsumerGoodsMember2021-01-012021-03-310001417398hi:ConsumerGoodsMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:ConsumerGoodsMemberhi:MilacronMember2020-10-012021-03-310001417398hi:ConsumerGoodsMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:ConsumerGoodsMember2020-10-012021-03-310001417398hi:FoodPharmaceuticalsMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:FoodPharmaceuticalsMemberhi:MilacronMember2021-01-012021-03-310001417398hi:FoodPharmaceuticalsMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:FoodPharmaceuticalsMember2021-01-012021-03-310001417398hi:FoodPharmaceuticalsMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:FoodPharmaceuticalsMemberhi:MilacronMember2020-10-012021-03-310001417398hi:FoodPharmaceuticalsMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:FoodPharmaceuticalsMember2020-10-012021-03-310001417398hi:ProcessEquipmentGroupMemberhi:CustomMoldersMember2021-01-012021-03-310001417398hi:MilacronMemberhi:CustomMoldersMember2021-01-012021-03-310001417398hi:BatesvilleSegmentMemberhi:CustomMoldersMember2021-01-012021-03-310001417398hi:CustomMoldersMember2021-01-012021-03-310001417398hi:ProcessEquipmentGroupMemberhi:CustomMoldersMember2020-10-012021-03-310001417398hi:MilacronMemberhi:CustomMoldersMember2020-10-012021-03-310001417398hi:BatesvilleSegmentMemberhi:CustomMoldersMember2020-10-012021-03-310001417398hi:CustomMoldersMember2020-10-012021-03-310001417398us-gaap:ConstructionMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398us-gaap:ConstructionMemberhi:MilacronMember2021-01-012021-03-310001417398us-gaap:ConstructionMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398us-gaap:ConstructionMember2021-01-012021-03-310001417398us-gaap:ConstructionMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398us-gaap:ConstructionMemberhi:MilacronMember2020-10-012021-03-310001417398us-gaap:ConstructionMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398us-gaap:ConstructionMember2020-10-012021-03-310001417398hi:PackagingMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:PackagingMemberhi:MilacronMember2021-01-012021-03-310001417398hi:PackagingMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:PackagingMember2021-01-012021-03-310001417398hi:PackagingMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:PackagingMemberhi:MilacronMember2020-10-012021-03-310001417398hi:PackagingMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:PackagingMember2020-10-012021-03-310001417398hi:MineralsMiningMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:MineralsMiningMemberhi:MilacronMember2021-01-012021-03-310001417398hi:MineralsMiningMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:MineralsMiningMember2021-01-012021-03-310001417398hi:MineralsMiningMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:MineralsMiningMemberhi:MilacronMember2020-10-012021-03-310001417398hi:MineralsMiningMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:MineralsMiningMember2020-10-012021-03-310001417398hi:ElectronicsMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:ElectronicsMemberhi:MilacronMember2021-01-012021-03-310001417398hi:ElectronicsMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:ElectronicsMember2021-01-012021-03-310001417398hi:ElectronicsMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:ElectronicsMemberhi:MilacronMember2020-10-012021-03-310001417398hi:ElectronicsMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:ElectronicsMember2020-10-012021-03-310001417398hi:MedicalMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:MedicalMemberhi:MilacronMember2021-01-012021-03-310001417398hi:MedicalMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:MedicalMember2021-01-012021-03-310001417398hi:MedicalMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:MedicalMemberhi:MilacronMember2020-10-012021-03-310001417398hi:MedicalMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:MedicalMember2020-10-012021-03-310001417398hi:DeathCareMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:DeathCareMemberhi:MilacronMember2021-01-012021-03-310001417398hi:DeathCareMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:DeathCareMember2021-01-012021-03-310001417398hi:DeathCareMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:DeathCareMemberhi:MilacronMember2020-10-012021-03-310001417398hi:DeathCareMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:DeathCareMember2020-10-012021-03-310001417398hi:OtherEndMarketsMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:OtherEndMarketsMemberhi:MilacronMember2021-01-012021-03-310001417398hi:OtherEndMarketsMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:OtherEndMarketsMember2021-01-012021-03-310001417398hi:OtherEndMarketsMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:OtherEndMarketsMemberhi:MilacronMember2020-10-012021-03-310001417398hi:OtherEndMarketsMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:OtherEndMarketsMember2020-10-012021-03-310001417398hi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:MilacronMember2021-01-012021-03-310001417398hi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:MilacronMember2020-10-012021-03-310001417398hi:BatesvilleSegmentMember2020-10-012021-03-310001417398srt:AmericasMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398srt:AmericasMemberhi:MilacronMember2022-01-012022-03-310001417398srt:AmericasMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398srt:AmericasMember2022-01-012022-03-310001417398srt:AmericasMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398srt:AmericasMemberhi:MilacronMember2021-10-012022-03-310001417398srt:AmericasMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398srt:AmericasMember2021-10-012022-03-310001417398srt:AsiaMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398srt:AsiaMemberhi:MilacronMember2022-01-012022-03-310001417398srt:AsiaMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398srt:AsiaMember2022-01-012022-03-310001417398srt:AsiaMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398srt:AsiaMemberhi:MilacronMember2021-10-012022-03-310001417398srt:AsiaMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398srt:AsiaMember2021-10-012022-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:MilacronMember2022-01-012022-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:EuropeTheMiddleEastAndAfricaMember2022-01-012022-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:MilacronMember2021-10-012022-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:EuropeTheMiddleEastAndAfricaMember2021-10-012022-03-310001417398srt:AmericasMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398srt:AmericasMemberhi:MilacronMember2021-01-012021-03-310001417398srt:AmericasMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398srt:AmericasMember2021-01-012021-03-310001417398srt:AmericasMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398srt:AmericasMemberhi:MilacronMember2020-10-012021-03-310001417398srt:AmericasMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398srt:AmericasMember2020-10-012021-03-310001417398srt:AsiaMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398srt:AsiaMemberhi:MilacronMember2021-01-012021-03-310001417398srt:AsiaMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398srt:AsiaMember2021-01-012021-03-310001417398srt:AsiaMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398srt:AsiaMemberhi:MilacronMember2020-10-012021-03-310001417398srt:AsiaMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398srt:AsiaMember2020-10-012021-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:MilacronMember2021-01-012021-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:EuropeTheMiddleEastAndAfricaMember2021-01-012021-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:MilacronMember2020-10-012021-03-310001417398hi:EuropeTheMiddleEastAndAfricaMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:EuropeTheMiddleEastAndAfricaMember2020-10-012021-03-310001417398hi:EquipmentProductRevenueMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:EquipmentProductRevenueMemberhi:MilacronMember2022-01-012022-03-310001417398hi:EquipmentProductRevenueMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:EquipmentProductRevenueMember2022-01-012022-03-310001417398hi:EquipmentProductRevenueMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:EquipmentProductRevenueMemberhi:MilacronMember2021-10-012022-03-310001417398hi:EquipmentProductRevenueMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:EquipmentProductRevenueMember2021-10-012022-03-310001417398hi:PartsAndServicesMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:PartsAndServicesMemberhi:MilacronMember2022-01-012022-03-310001417398hi:PartsAndServicesMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398hi:PartsAndServicesMember2022-01-012022-03-310001417398hi:PartsAndServicesMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:PartsAndServicesMemberhi:MilacronMember2021-10-012022-03-310001417398hi:PartsAndServicesMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398hi:PartsAndServicesMember2021-10-012022-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:MilacronMember2022-01-012022-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398us-gaap:ProductAndServiceOtherMember2022-01-012022-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:MilacronMember2021-10-012022-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398us-gaap:ProductAndServiceOtherMember2021-10-012022-03-310001417398hi:ProcessEquipmentGroupMemberus-gaap:EquipmentMember2021-01-012021-03-310001417398hi:MilacronMemberus-gaap:EquipmentMember2021-01-012021-03-310001417398hi:EquipmentProductRevenueMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:EquipmentProductRevenueMember2021-01-012021-03-310001417398hi:EquipmentProductRevenueMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:MilacronMemberus-gaap:EquipmentMember2020-10-012021-03-310001417398hi:EquipmentProductRevenueMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:EquipmentProductRevenueMember2020-10-012021-03-310001417398hi:PartsAndServicesMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398hi:PartsAndServicesMemberhi:MilacronMember2021-01-012021-03-310001417398hi:PartsAndServicesMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398hi:PartsAndServicesMember2021-01-012021-03-310001417398hi:PartsAndServicesMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398hi:PartsAndServicesMemberhi:MilacronMember2020-10-012021-03-310001417398hi:PartsAndServicesMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398hi:PartsAndServicesMember2020-10-012021-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:MilacronMember2021-01-012021-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398us-gaap:ProductAndServiceOtherMember2021-01-012021-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:MilacronMember2020-10-012021-03-310001417398us-gaap:ProductAndServiceOtherMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398us-gaap:ProductAndServiceOtherMember2020-10-012021-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:MilacronMember2022-01-012022-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398us-gaap:TransferredAtPointInTimeMember2022-01-012022-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:MilacronMember2021-10-012022-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398us-gaap:TransferredAtPointInTimeMember2021-10-012022-03-310001417398us-gaap:TransferredOverTimeMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398us-gaap:TransferredOverTimeMemberhi:MilacronMember2022-01-012022-03-310001417398us-gaap:TransferredOverTimeMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398us-gaap:TransferredOverTimeMember2022-01-012022-03-310001417398us-gaap:TransferredOverTimeMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398us-gaap:TransferredOverTimeMemberhi:MilacronMember2021-10-012022-03-310001417398us-gaap:TransferredOverTimeMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398us-gaap:TransferredOverTimeMember2021-10-012022-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:MilacronMember2021-01-012021-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398us-gaap:TransferredAtPointInTimeMember2021-01-012021-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:MilacronMember2020-10-012021-03-310001417398us-gaap:TransferredAtPointInTimeMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398us-gaap:TransferredAtPointInTimeMember2020-10-012021-03-310001417398us-gaap:TransferredOverTimeMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398us-gaap:TransferredOverTimeMemberhi:MilacronMember2021-01-012021-03-310001417398us-gaap:TransferredOverTimeMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398us-gaap:TransferredOverTimeMember2021-01-012021-03-310001417398us-gaap:TransferredOverTimeMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398us-gaap:TransferredOverTimeMemberhi:MilacronMember2020-10-012021-03-310001417398us-gaap:TransferredOverTimeMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398us-gaap:TransferredOverTimeMember2020-10-012021-03-310001417398hi:TerraSourceGlobalMember2021-09-300001417398hi:RedValveMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2020-12-310001417398hi:RedValveMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2020-12-312020-12-310001417398hi:RedValveMemberus-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember2021-10-012022-03-310001417398us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberhi:ABELMember2021-03-100001417398us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberhi:ABELMember2021-03-102021-03-100001417398us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberhi:ABELMember2021-01-012021-03-310001417398us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberhi:ABELMember2020-10-012021-03-310001417398us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberhi:ABELMember2022-01-012022-03-310001417398us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMemberhi:ABELMember2021-10-012022-03-310001417398hi:TerraSourceGlobalMember2021-10-222021-10-220001417398hi:TerraSourceGlobalMember2021-10-220001417398hi:TerraSourceGlobalMembersrt:SubsidiariesMember2021-10-222021-10-220001417398hi:TerraSourceGlobalMember2021-10-012022-03-310001417398srt:MinimumMember2021-10-012022-03-310001417398srt:MaximumMember2021-10-012022-03-310001417398us-gaap:CustomerRelationshipsMember2022-03-310001417398us-gaap:CustomerRelationshipsMember2021-09-300001417398us-gaap:TechnologyBasedIntangibleAssetsMember2022-03-310001417398us-gaap:TechnologyBasedIntangibleAssetsMember2021-09-300001417398us-gaap:ComputerSoftwareIntangibleAssetMember2022-03-310001417398us-gaap:ComputerSoftwareIntangibleAssetMember2021-09-300001417398us-gaap:TradeNamesMember2022-03-310001417398us-gaap:TradeNamesMember2021-09-300001417398hi:ProcessEquipmentGroupMember2021-09-300001417398hi:MilacronMember2021-09-300001417398hi:BatesvilleServicesIncMember2021-09-300001417398hi:BatesvilleServicesIncMember2021-10-012022-03-310001417398hi:ProcessEquipmentGroupMember2022-03-310001417398hi:MilacronMember2022-03-310001417398hi:BatesvilleServicesIncMember2022-03-310001417398hi:A4000SeniorUnsecuredNotesMember2022-03-310001417398hi:A4000SeniorUnsecuredNotesMember2021-09-300001417398us-gaap:SeniorNotesMember2022-03-310001417398us-gaap:SeniorNotesMember2021-09-300001417398hi:A350MillionSeniorUnsecuredNotesMember2022-03-310001417398hi:A350MillionSeniorUnsecuredNotesMember2021-09-300001417398us-gaap:UnsecuredDebtMember2022-03-310001417398us-gaap:UnsecuredDebtMember2021-09-300001417398us-gaap:LineOfCreditMember2022-03-310001417398us-gaap:LineOfCreditMember2021-09-300001417398us-gaap:RevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2022-03-310001417398us-gaap:LineOfCreditMember2022-01-012022-03-310001417398us-gaap:LineOfCreditMember2021-10-012022-03-310001417398us-gaap:LineOfCreditMember2021-01-012021-03-310001417398us-gaap:LineOfCreditMember2020-10-012021-03-310001417398hi:OtherFinancingAgreementsMember2022-03-310001417398hi:OtherFinancingAgreementsMember2021-09-300001417398us-gaap:LetterOfCreditMemberhi:OtherFinancingAgreementsMember2022-03-31iso4217:EUR00014173982020-10-012021-09-300001417398hi:LGFacilityAgreementAmendmentMember2020-10-012021-09-300001417398hi:A4000SeniorUnsecuredNotesMember2020-06-160001417398us-gaap:UnsecuredDebtMember2014-12-150001417398country:US2022-01-012022-03-310001417398country:US2021-01-012021-03-310001417398us-gaap:ForeignPlanMember2022-01-012022-03-310001417398us-gaap:ForeignPlanMember2021-01-012021-03-310001417398country:US2021-10-012022-03-310001417398country:US2020-10-012021-03-310001417398us-gaap:ForeignPlanMember2021-10-012022-03-310001417398us-gaap:ForeignPlanMember2020-10-012021-03-310001417398us-gaap:PerformanceSharesMember2021-10-012022-03-310001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-09-300001417398us-gaap:AccumulatedTranslationAdjustmentMember2021-09-300001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-09-300001417398us-gaap:ParentMember2021-09-300001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-10-012022-03-310001417398us-gaap:AccumulatedTranslationAdjustmentMember2021-10-012022-03-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-10-012022-03-310001417398us-gaap:ParentMember2021-10-012022-03-310001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-03-310001417398us-gaap:AccumulatedTranslationAdjustmentMember2022-03-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-03-310001417398us-gaap:ParentMember2022-03-310001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-09-300001417398us-gaap:AccumulatedTranslationAdjustmentMember2020-09-300001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-09-300001417398us-gaap:ParentMember2020-09-300001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2020-10-012021-03-310001417398us-gaap:AccumulatedTranslationAdjustmentMember2020-10-012021-03-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2020-10-012021-03-310001417398us-gaap:ParentMember2020-10-012021-03-310001417398us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2021-03-310001417398us-gaap:AccumulatedTranslationAdjustmentMember2021-03-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-03-310001417398us-gaap:ParentMember2021-03-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentNetLossRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentPriorServiceCostRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001417398us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2022-01-012022-03-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentNetLossRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-012022-03-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentPriorServiceCostRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-012022-03-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-012022-03-310001417398us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-10-012022-03-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentNetLossRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentPriorServiceCostRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001417398us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-01-012021-03-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentNetLossRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-10-012021-03-310001417398hi:AccumulatedDefinedBenefitPlansAdjustmentPriorServiceCostRecognizedMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-10-012021-03-310001417398us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-10-012021-03-310001417398us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-10-012021-03-310001417398hi:TimeBasedStockAwardsMember2021-10-012022-03-310001417398us-gaap:PerformanceSharesMember2021-10-012022-03-310001417398srt:MinimumMemberhi:GeneralClaimsAndLawsuitMember2021-10-012022-03-310001417398us-gaap:FairValueInputsLevel1Member2022-03-310001417398us-gaap:FairValueInputsLevel2Member2022-03-310001417398us-gaap:FairValueInputsLevel3Member2022-03-310001417398hi:A2021NotesMember2022-03-310001417398us-gaap:FairValueInputsLevel1Memberhi:A2021NotesMember2022-03-310001417398hi:A2021NotesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001417398us-gaap:FairValueInputsLevel3Memberhi:A2021NotesMember2022-03-310001417398hi:A2020NotesMember2022-03-310001417398us-gaap:FairValueInputsLevel1Memberhi:A2020NotesMember2022-03-310001417398hi:A2020NotesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001417398us-gaap:FairValueInputsLevel3Memberhi:A2020NotesMember2022-03-310001417398hi:A2019NotesMember2022-03-310001417398us-gaap:FairValueInputsLevel1Memberhi:A2019NotesMember2022-03-310001417398hi:A2019NotesMemberus-gaap:FairValueInputsLevel2Member2022-03-310001417398us-gaap:FairValueInputsLevel3Memberhi:A2019NotesMember2022-03-310001417398us-gaap:FairValueInputsLevel1Memberus-gaap:UnsecuredDebtMember2022-03-310001417398us-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel2Member2022-03-310001417398us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMember2022-03-310001417398us-gaap:FairValueInputsLevel1Member2021-09-300001417398us-gaap:FairValueInputsLevel2Member2021-09-300001417398us-gaap:FairValueInputsLevel3Member2021-09-300001417398hi:A2021NotesMember2021-09-300001417398us-gaap:FairValueInputsLevel1Memberhi:A2021NotesMember2021-09-300001417398hi:A2021NotesMemberus-gaap:FairValueInputsLevel2Member2021-09-300001417398us-gaap:FairValueInputsLevel3Memberhi:A2021NotesMember2021-09-300001417398hi:A2020NotesMember2021-09-300001417398us-gaap:FairValueInputsLevel1Memberhi:A2020NotesMember2021-09-300001417398hi:A2020NotesMemberus-gaap:FairValueInputsLevel2Member2021-09-300001417398us-gaap:FairValueInputsLevel3Memberhi:A2020NotesMember2021-09-300001417398hi:A2019NotesMember2021-09-300001417398us-gaap:FairValueInputsLevel1Memberhi:A2019NotesMember2021-09-300001417398hi:A2019NotesMemberus-gaap:FairValueInputsLevel2Member2021-09-300001417398us-gaap:FairValueInputsLevel3Memberhi:A2019NotesMember2021-09-300001417398us-gaap:FairValueInputsLevel1Memberus-gaap:UnsecuredDebtMember2021-09-300001417398us-gaap:UnsecuredDebtMemberus-gaap:FairValueInputsLevel2Member2021-09-300001417398us-gaap:FairValueInputsLevel3Memberus-gaap:UnsecuredDebtMember2021-09-300001417398us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2022-03-310001417398us-gaap:ForeignExchangeForwardMemberus-gaap:CashFlowHedgingMember2021-09-300001417398hi:ProcessEquipmentGroupSegmentMember2022-01-012022-03-310001417398hi:ProcessEquipmentGroupSegmentMember2021-01-012021-03-310001417398hi:ProcessEquipmentGroupSegmentMember2021-10-012022-03-310001417398hi:ProcessEquipmentGroupSegmentMember2020-10-012021-03-310001417398us-gaap:OperatingSegmentsMember2022-01-012022-03-310001417398us-gaap:OperatingSegmentsMember2021-01-012021-03-310001417398us-gaap:OperatingSegmentsMember2021-10-012022-03-310001417398us-gaap:OperatingSegmentsMember2020-10-012021-03-310001417398hi:ProcessEquipmentGroupSegmentMemberus-gaap:OperatingSegmentsMember2022-01-012022-03-310001417398hi:ProcessEquipmentGroupSegmentMemberus-gaap:OperatingSegmentsMember2021-01-012021-03-310001417398hi:ProcessEquipmentGroupSegmentMemberus-gaap:OperatingSegmentsMember2021-10-012022-03-310001417398hi:ProcessEquipmentGroupSegmentMemberus-gaap:OperatingSegmentsMember2020-10-012021-03-310001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2022-01-012022-03-310001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2021-01-012021-03-310001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2021-10-012022-03-310001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2020-10-012021-03-310001417398us-gaap:OperatingSegmentsMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398us-gaap:OperatingSegmentsMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398us-gaap:OperatingSegmentsMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398us-gaap:OperatingSegmentsMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398us-gaap:CorporateNonSegmentMember2022-01-012022-03-310001417398us-gaap:CorporateNonSegmentMember2021-01-012021-03-310001417398us-gaap:CorporateNonSegmentMember2021-10-012022-03-310001417398us-gaap:CorporateNonSegmentMember2020-10-012021-03-310001417398country:US2022-01-012022-03-310001417398country:US2021-01-012021-03-310001417398country:US2021-10-012022-03-310001417398country:US2020-10-012021-03-310001417398country:DE2022-01-012022-03-310001417398country:DE2021-01-012021-03-310001417398country:DE2021-10-012022-03-310001417398country:DE2020-10-012021-03-310001417398country:CN2022-01-012022-03-310001417398country:CN2021-01-012021-03-310001417398country:CN2021-10-012022-03-310001417398country:CN2020-10-012021-03-310001417398country:IN2022-01-012022-03-310001417398country:IN2021-01-012021-03-310001417398country:IN2021-10-012022-03-310001417398country:IN2020-10-012021-03-310001417398hi:InternationalMember2022-01-012022-03-310001417398hi:InternationalMember2021-01-012021-03-310001417398hi:InternationalMember2021-10-012022-03-310001417398hi:InternationalMember2020-10-012021-03-310001417398hi:ProcessEquipmentGroupSegmentMemberus-gaap:OperatingSegmentsMember2022-03-310001417398hi:ProcessEquipmentGroupSegmentMemberus-gaap:OperatingSegmentsMember2021-09-300001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2022-03-310001417398us-gaap:OperatingSegmentsMemberhi:MilacronMember2021-09-300001417398us-gaap:OperatingSegmentsMemberhi:BatesvilleSegmentMember2022-03-310001417398us-gaap:OperatingSegmentsMemberhi:BatesvilleSegmentMember2021-09-300001417398us-gaap:CorporateNonSegmentMember2022-03-310001417398us-gaap:CorporateNonSegmentMember2021-09-300001417398country:US2022-03-310001417398country:US2021-09-300001417398country:DE2022-03-310001417398country:DE2021-09-300001417398country:CN2022-03-310001417398country:CN2021-09-300001417398country:IN2022-03-310001417398country:IN2021-09-300001417398hi:InternationalMember2022-03-310001417398hi:InternationalMember2021-09-300001417398us-gaap:CostOfGoodsSegmentMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398us-gaap:OperatingExpenseMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398us-gaap:OperatingExpenseMemberhi:ProcessEquipmentGroupMember2021-01-012021-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:MilacronMember2022-01-012022-03-310001417398us-gaap:OperatingExpenseMemberhi:MilacronMember2022-01-012022-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:MilacronMember2021-01-012021-03-310001417398us-gaap:OperatingExpenseMemberhi:MilacronMember2021-01-012021-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398us-gaap:OperatingExpenseMemberhi:BatesvilleSegmentMember2022-01-012022-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398us-gaap:OperatingExpenseMemberhi:BatesvilleSegmentMember2021-01-012021-03-310001417398us-gaap:CostOfGoodsSegmentMemberus-gaap:CorporateNonSegmentMember2022-01-012022-03-310001417398us-gaap:CorporateNonSegmentMemberus-gaap:OperatingExpenseMember2022-01-012022-03-310001417398us-gaap:CostOfGoodsSegmentMemberus-gaap:CorporateNonSegmentMember2021-01-012021-03-310001417398us-gaap:CorporateNonSegmentMemberus-gaap:OperatingExpenseMember2021-01-012021-03-310001417398us-gaap:CostOfGoodsSegmentMember2022-01-012022-03-310001417398us-gaap:OperatingExpenseMember2022-01-012022-03-310001417398us-gaap:CostOfGoodsSegmentMember2021-01-012021-03-310001417398us-gaap:OperatingExpenseMember2021-01-012021-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398us-gaap:OperatingExpenseMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398us-gaap:OperatingExpenseMemberhi:ProcessEquipmentGroupMember2020-10-012021-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:MilacronMember2021-10-012022-03-310001417398us-gaap:OperatingExpenseMemberhi:MilacronMember2021-10-012022-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:MilacronMember2020-10-012021-03-310001417398us-gaap:OperatingExpenseMemberhi:MilacronMember2020-10-012021-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398us-gaap:OperatingExpenseMemberhi:BatesvilleSegmentMember2021-10-012022-03-310001417398us-gaap:CostOfGoodsSegmentMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398us-gaap:OperatingExpenseMemberhi:BatesvilleSegmentMember2020-10-012021-03-310001417398us-gaap:CostOfGoodsSegmentMemberus-gaap:CorporateNonSegmentMember2021-10-012022-03-310001417398us-gaap:CorporateNonSegmentMemberus-gaap:OperatingExpenseMember2021-10-012022-03-310001417398us-gaap:CostOfGoodsSegmentMemberus-gaap:CorporateNonSegmentMember2020-10-012021-03-310001417398us-gaap:CorporateNonSegmentMemberus-gaap:OperatingExpenseMember2020-10-012021-03-310001417398us-gaap:CostOfGoodsSegmentMember2021-10-012022-03-310001417398us-gaap:OperatingExpenseMember2021-10-012022-03-310001417398us-gaap:CostOfGoodsSegmentMember2020-10-012021-03-310001417398us-gaap:OperatingExpenseMember2020-10-012021-03-310001417398srt:MinimumMemberhi:CoperionGmbHMemberhi:ProcessEquipmentGroupMember2020-10-012021-09-300001417398srt:MaximumMemberhi:CoperionGmbHMemberhi:ProcessEquipmentGroupMember2020-10-012021-09-300001417398hi:CoperionGmbHMemberus-gaap:CostOfSalesMemberhi:ProcessEquipmentGroupMember2022-01-012022-03-310001417398hi:CoperionGmbHMemberus-gaap:CostOfSalesMemberhi:ProcessEquipmentGroupMember2021-10-012022-03-310001417398hi:CoperionGmbHMember2022-03-31
Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 

FORM 10-Q
 
 Quarterly Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
For the quarterly period ended March 31, 2022

OR

  Transition Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
 
For the transition period from _____ to _____

Commission File Number. 001-33794 
HILLENBRAND, INC.
(Exact name of registrant as specified in its charter)
Indiana 26-1342272
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
   
One Batesville Boulevard  
Batesville,Indiana 47006
(Address of principal executive offices) (Zip Code)
(812) 934-7500
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, without par valueHINew York Stock Exchange
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No 
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes   No 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer  Accelerated filer Emerging growth company
Non-accelerated filerSmaller reporting company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes   No  

The registrant had 71,712,927 shares of common stock, no par value per share, outstanding as of May 4, 2022.


Table of Contents

HILLENBRAND, INC.
INDEX TO FORM 10-Q
 
  Page
  
   
 
   
 
   
 
   
 
   
 
   
 
   
   
   
   
  
   
   
   
   
 
1

Table of Contents
PART IFINANCIAL INFORMATION

Item 1.                FINANCIAL STATEMENTS
 
Hillenbrand, Inc.
Consolidated Statements of Operations (Unaudited)
(in millions, except per share data)
 
Three Months Ended
March 31,
Six Months Ended
March 31,
 2022202120222021
Net revenue$742.0 $722.3 $1,470.4 $1,414.8 
Cost of goods sold498.7 476.4 989.8 924.7 
Gross profit243.3 245.9 480.6 490.1 
Operating expenses131.8 138.0 259.9 269.6 
Amortization expense13.7 14.1 27.4 27.7 
(Gain) loss on divestitures (34.1)3.1 (65.7)
Interest expense17.3 19.5 35.2 40.7 
Other income, net4.7 1.0 3.6 0.6 
Income before income taxes85.2 109.4 158.6 218.4 
Income tax expense29.4 30.4 52.7 61.7 
Consolidated net income55.8 79.0 105.9 156.7 
Less: Net income attributable to noncontrolling interests1.5 0.9 2.6 2.2 
Net income attributable to Hillenbrand$54.3 $78.1 $103.3 $154.5 
Net income attributable to Hillenbrand — per share of common stock:  
Basic earnings per share$0.74 $1.04 $1.42 $2.05 
Diluted earnings per share$0.74 $1.03 $1.40 $2.04 
Weighted average shares outstanding (basic)73.1 75.5 72.9 75.4 
Weighted average shares outstanding (diluted)73.7 76.2 73.5 75.8 

See Condensed Notes to Consolidated Financial Statements


2

Table of Contents
Hillenbrand, Inc.
Consolidated Statements of Comprehensive Income (Unaudited)
(in millions)
 
Three Months Ended
March 31,
Six Months Ended
March 31,
 2022202120222021
Consolidated net income$55.8 $79.0 $105.9 $156.7 
Changes in other comprehensive (loss) income, net of tax:
Currency translation adjustment(7.4)(45.2)(5.0)14.1 
Pension and postretirement0.7 0.6 1.4 1.8 
Change in net unrealized gain (loss) on derivative instruments1.2 (0.5)1.9 1.2 
Total changes in other comprehensive (loss) income, net of tax(5.5)(45.1)(1.7)17.1 
Consolidated comprehensive income50.3 33.9 104.2 173.8 
Less: Comprehensive income attributable to noncontrolling interests1.3 0.9 2.3 2.3 
Comprehensive income attributable to Hillenbrand$49.0 $33.0 $101.9 $171.5 
 
See Condensed Notes to Consolidated Financial Statements

3

Table of Contents
Hillenbrand, Inc.
Consolidated Balance Sheets
(in millions)
March 31, 2022 (unaudited)September 30,
2021
ASSETS  
Current Assets  
Cash and cash equivalents$444.8 $446.1 
Trade receivables, net306.0 323.5 
Receivables from long-term manufacturing contracts, net173.5 121.9 
Inventories, net481.2 411.6 
Prepaid expenses and other current assets104.5 75.2 
Current assets held for sale 56.2 
Total current assets1,510.0 1,434.5 
Property, plant, and equipment, net281.3 295.1 
Operating lease right-of-use assets, net136.0 138.1 
Intangible assets, net885.1 913.9 
Goodwill1,159.9 1,168.6 
Other long-term assets92.7 64.7 
Total Assets$4,065.0 $4,014.9 
LIABILITIES  
Current Liabilities  
Trade accounts payable$428.4 $361.3 
Liabilities from long-term manufacturing contracts and advances299.9 296.6 
Accrued compensation99.9 123.5 
Current liabilities held for sale 18.9 
Other current liabilities246.1 234.8 
Total current liabilities1,074.3 1,035.1 
Long-term debt1,214.0 1,212.9 
Accrued pension and postretirement healthcare142.6 151.6 
Operating lease liabilities104.4 105.6 
Deferred income taxes190.7 206.7 
Other long-term liabilities61.2 70.8 
Total Liabilities2,787.2 2,782.7 
Commitments and contingencies (Note 15)
SHAREHOLDERS’ EQUITY  
Common stock, no par value (75.8 and 75.8 shares issued, 72.4 and 72.7 shares outstanding)  
Additional paid-in capital717.3 725.4 
Retained earnings737.1 666.2 
Treasury stock (3.4 and 3.1 shares, at cost)(152.2)(135.7)
Accumulated other comprehensive loss(47.7)(46.3)
Hillenbrand Shareholders’ Equity1,254.5 1,209.6 
Noncontrolling interests23.3 22.6 
Total Shareholders’ Equity1,277.8 1,232.2 
Total Liabilities and Shareholders’ Equity$4,065.0 $4,014.9 

 See Condensed Notes to Consolidated Financial Statements
4

Table of Contents
Hillenbrand, Inc.
Consolidated Statements of Cash Flows (Unaudited)
(in millions)
Six Months Ended
March 31,
 20222021
Operating Activities  
Consolidated net income$105.9 $156.7 
Adjustments to reconcile consolidated net income to cash provided by operating activities:  
Depreciation and amortization54.9 57.6 
Deferred income taxes(10.9)15.0 
Amortization of deferred financing costs1.8 4.6 
Share-based compensation12.0 10.4 
Loss (gain) on divestitures3.1 (65.7)
Trade accounts receivable, net and receivables from long-term manufacturing contracts(40.0)(21.0)
Inventories, net(73.6)(5.6)
Prepaid expenses and other current assets(20.8)(4.1)
Trade accounts payable72.3 21.2 
Liabilities from long-term manufacturing contracts and advances,
accrued compensation, and other current liabilities(22.1)83.9 
Income taxes payable17.3 4.3 
Defined benefit plan and postretirement funding(4.7)(4.6)
Defined benefit plan and postretirement expense0.5 1.4 
Other, net(5.0)4.9 
   Net cash provided by operating activities90.7 259.0 
Investing Activities  
Capital expenditures(20.0)(11.6)
Proceeds from sales of property, plant, and equipment1.6  
(Payments) proceeds from divestitures, net of cash divested(4.5)165.7 
Net cash (used in) provided by investing activities(22.9)154.1 
Financing Activities  
Proceeds from issuance of long-term debt 350.0 
Repayments on long-term debt (688.8)
Proceeds from revolving credit facilities 395.0 
Repayments on revolving credit facilities (395.0)
Payment of deferred financing costs (3.5)
Payments of dividends on common stock(31.7)(32.3)
Repurchases of common stock(55.5) 
Proceeds from stock option exercises 24.3 8.7 
Payments for employee taxes on net settlement equity awards(6.1)(2.9)
Other, net(1.5)(1.3)
Net cash used in financing activities(70.5)(370.1)
Effect of exchange rates on cash and cash equivalents(2.2)(7.5)
Net cash flows(4.9)35.5 
Cash, cash equivalents, and restricted cash:  
At beginning of period450.9 311.8 
At end of period$446.0 $347.3 
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheets that sum to the total of the same amounts shown in the Consolidated Statements of Cash Flows:
March 31, 2022March 31, 2021
Cash and cash equivalents$444.8 $344.9 
Short-term restricted cash included in other current assets1.2 2.4 
Total cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows$446.0 $347.3 

See Condensed Notes to Consolidated Financial Statements
5

Table of Contents
Hillenbrand, Inc.
Consolidated Statements of Shareholders’ Equity (Unaudited)
(in millions)
Three Months Ended March 31, 2022
 Common StockAdditional
Paid-in
Capital
Retained
Earnings
Treasury StockAccumulated
Other
Comprehensive
Loss
Noncontrolling
Interests
Total
 SharesSharesAmount
Balance at December 31, 202175.8 $714.8 $699.1 3.2 $(138.9)$(42.4)$22.0 $1,254.6 
Total other comprehensive loss, net of tax— — — — — (5.3)(0.2)(5.5)
Net income— — 54.3 — — — 1.5 55.8 
Repurchases of common stock— — — 0.6 (26.6)— — (26.6)
Issuance/retirement of stock for stock awards/options— (4.0)— (0.4)13.3 — — 9.3 
Share-based compensation— 6.1 — — — — — 6.1 
Dividends ($0.2175 per share)— 0.4 (16.3)— — — — (15.9)
Balance at March 31, 202275.8 $717.3 $737.1 3.4 $(152.2)$(47.7)$23.3 $1,277.8 
Six Months Ended March 31, 2022
Common StockAdditional
Paid-in
Capital
Retained
Earnings
Treasury StockAccumulated
Other
Comprehensive
Loss
Noncontrolling
Interests
Total
SharesSharesAmount
Balance at September 30, 202175.8 $725.4 $666.2 3.1 $(135.7)$(46.3)$22.6 $1,232.2 
Total other comprehensive loss, net of tax— — — — — (1.4)(0.3)(1.7)
Net income— — 103.3 — — — 2.6 105.9 
Repurchases of common stock— — — 1.2 (55.5)— — (55.5)
Issuance/retirement of stock for stock awards/options— (20.8)— (0.9)39.0 — — 18.2 
Share-based compensation— 12.0 — — — — — 12.0 
Dividends ($0.4350 per share)— 0.7 (32.4)— — — (1.6)(33.3)
Balance at March 31, 202275.8 $717.3 $737.1 3.4 $(152.2)$(47.7)$23.3 $1,277.8 


6

Table of Contents
Three Months Ended March 31, 2021
 Common StockAdditional
Paid-in
Capital
Retained
Earnings
Treasury StockAccumulated
Other
Comprehensive
Loss
Noncontrolling
Interests
Total
 SharesSharesAmount
Balance at December 31, 202075.8 $717.2 $541.4 0.7 $(32.0)$(40.7)$20.4 $1,206.3 
Total other comprehensive loss, net of tax— — — — — (45.1) (45.1)
Net income— — 78.1 — — — 0.9 79.0 
Issuance/retirement of stock for stock awards/options— (3.1)— (0.1)8.6 — — 5.5 
Share-based compensation— 6.2 — — — — — 6.2 
Dividends ($0.2150 per share)— 0.2 (16.4)— — —  (16.2)
Balance at March 31, 202175.8 $720.5 $603.1 0.6 $(23.4)$(85.8)$21.3 $1,235.7 
Six Months Ended March 31, 2021
Common StockAdditional
Paid-in
Capital
Retained
Earnings
Treasury StockAccumulated
Other
Comprehensive
Loss
Noncontrolling
Interests
Total
SharesSharesAmount
Balance at September 30, 202075.8 $723.6 $481.4 1.0 $(43.2)$(102.8)$20.4 $1,079.4 
Total other comprehensive income, net of tax— — — — — 17.0 0.1 17.1 
Net income— — 154.5 — — — 2.2 156.7 
Issuance/retirement of stock for stock awards/options— (14.0)— (0.4)19.8 — — 5.8 
Share-based compensation— 10.4 — — — — — 10.4 
Dividends ($0.4300 per share)— 0.5 (32.8)— — — (1.4)(33.7)
Balance at March 31, 202175.8 $720.5 $603.1 0.6 $(23.4)$(85.8)$21.3 $1,235.7 



See Condensed Notes to Consolidated Financial Statements

7

Table of Contents
Hillenbrand, Inc.
Condensed Notes to Consolidated Financial Statements (Unaudited)
(in millions, except share and per share data)
 
1.Background and Basis of Presentation
 
Hillenbrand, Inc. (the “Company” or “Hillenbrand”) is a global diversified industrial company with multiple leading brands that serve a wide variety of industries around the world.  The Company strives to provide superior return for our shareholders, exceptional value for our customers, great professional opportunities for our employees, and to be responsible to our communities through deployment of the Hillenbrand Operating Model (“HOM”). The HOM is a consistent and repeatable framework designed to produce sustainable and predictable results.  The HOM describes the Company’s mission, vision, values, and mindset as leaders; applies our management practices in Strategy Management, Segmentation, Lean, Talent Development, and Acquisitions; and prescribes three steps (Understand, Focus, and Grow) designed to make the Company’s businesses both bigger and better.  The Company’s goal is to continue developing Hillenbrand as a world-class global diversified industrial company through the deployment of the HOM.

Hillenbrand’s portfolio is composed of three reportable operating segments. Advanced Process Solutions designs, develops, manufactures, and services highly engineered industrial equipment and systems around the world. Molding Technology Solutions is a global leader in highly engineered and customized equipment, systems, and service in plastic technology and processing. Batesville is a recognized leader in the death care industry in North America. “Hillenbrand,” the “Company,” “we,” “us,” “our,” and similar words refer to Hillenbrand and its subsidiaries unless context otherwise requires.
 
The accompanying unaudited Consolidated Financial Statements include the accounts of Hillenbrand and its subsidiaries.  They also include two subsidiaries where the Company’s ownership percentage is less than 100%.  The Company’s fiscal year ends on September 30.  Unless otherwise stated, references to years relate to fiscal years.
 
These unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements and therefore do not include all information required in accordance with United States generally accepted accounting principles (“GAAP”).  The unaudited Consolidated Financial Statements have been prepared on the same basis as, and should be read in conjunction with, the audited Consolidated Financial Statements and notes thereto included in the Company’s latest Annual Report on Form 10-K for the year ended September 30, 2021, as filed with the SEC on November 17, 2021. In the opinion of management, these unaudited Consolidated Financial Statements reflect all adjustments necessary to present a fair statement of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented and are normal and recurring in nature. The interim period results are subject to variation and are not necessarily indicative of the results of operations to be expected for the full fiscal year.
 
The preparation of the Consolidated Financial Statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of net revenue and expenses during the period.  Actual results could differ from those estimates.  Examples of such estimates include, but are not limited to, revenue recognition under the overtime method, establishment of reserves related to customer rebates, doubtful accounts, warranties, early-pay discounts, inventories, income taxes, litigation, self-insurance, and progress toward achievement of performance criteria under incentive compensation programs.

As a result of the Russian Federation’s invasion of Ukraine in February 2022 (the “Ukraine War”), various nations, including the U.S., have instituted economic sanctions and other responsive measures, which have resulted in an increased level of global economic and political uncertainty. Any such geopolitical instability and uncertainty could have a negative impact on our ability to sell to, ship products to, collect payments from, and support customers in certain regions. The effects of the Ukraine War and such associated measures on management’s estimates and results of operations through March 31, 2022 are reflected in the Consolidated Financial Statements. As of and for the three and six months ended March 31, 2022, the effects of the Ukraine War have not had a material impact on the Consolidated Financial Statements.

In addition, it has now been two years since March 11, 2020, when the World Health Organization declared the outbreak of the novel strain of coronavirus (“COVID-19”) a global pandemic and recommended containment and mitigation measures worldwide, and the effects of the COVID-19 pandemic and such associated measures on management’s estimates and results of operations through March 31, 2022 are reflected in the Consolidated Financial Statements. Given the unprecedented nature of the ongoing COVID-19 pandemic, the Company cannot reasonably estimate the full extent of the impact that the COVID-19 pandemic will continue to have on its consolidated financial condition, and the consolidated results of operations, and cash
8

Table of Contents
flows in the foreseeable future. The ultimate impact of the COVID-19 pandemic on the Company is highly uncertain and will depend on future developments, and such impacts could exist for an extended period of time, even after the ongoing COVID-19 pandemic subsides or if variant strains of the virus further impact the global economy or the Company.

Events and changes in circumstances arising after March 31, 2022, including those resulting from the ongoing impacts of the Ukraine War and the COVID-19 pandemic, will be reflected in management’s estimates for future periods in subsequent periodic filings.

2.Summary of Significant Accounting Policies
 
The significant accounting policies used in preparing the Consolidated Financial Statements are consistent with the accounting policies described in the Company’s Annual Report on Form 10-K as of and for the year ended September 30, 2021, except as described below.

Recently Adopted Accounting Standards
 
In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12 clarifies and simplifies accounting for income taxes by eliminating certain exceptions for intraperiod tax allocation principles, the methodology for calculating income tax rates in an interim period, and recognition of deferred taxes for outside basis differences in an investment, among other updates. ASU 2019-12 became effective for the Company’s fiscal year beginning on October 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Consolidated Financial Statements.

No other new accounting pronouncements recently adopted or issued had or are expected to have a material impact on the Consolidated Financial Statements.

3.Revenue Recognition

Net revenue includes gross revenue less sales discounts, customer rebates, sales incentives, and product returns, all of which require the Company to make estimates for the portion of these allowances that have yet to be credited or paid to customers. The Company estimates these allowances using the expected value method, which is based upon historical rates and projections of customer purchases toward contractual rebate thresholds.

Contract balances

The balance in receivables from long-term manufacturing contracts at March 31, 2022 and September 30, 2021 was $173.5 and $121.9, respectively. The change was driven by the impact of net revenue recognized prior to billings. The balance in the liabilities from long-term manufacturing contracts and advances at March 31, 2022 and September 30, 2021 was $299.9 and $296.6, respectively, and consists primarily of cash payments received or due in advance of satisfying performance obligations. The net revenue recognized for the six months ended March 31, 2022 and 2021 related to liabilities from long-term manufacturing contracts and advances as of September 30, 2021 and 2020 was $171.3 and $97.6, respectively. During the three and six months ended March 31, 2022 and 2021, the adjustments related to performance obligations satisfied in previous periods were immaterial.

Transaction price allocated to the remaining performance obligations
                                            
As of March 31, 2022, the aggregate amount of transaction price of remaining performance obligations for the Company, which corresponds to backlog as defined in Part I, Item 2 of this Form 10-Q, was $1,700.5. Approximately 78% of these performance obligations are expected to be satisfied over the next twelve months, and the remaining performance obligations, primarily within one to three years.

9

Table of Contents
Disaggregation of revenue

The following tables present net revenue by end market:
Three Months Ended March 31, 2022Six Months Ended March 31, 2022
Advanced Process SolutionsMolding Technology SolutionsBatesvilleTotalAdvanced Process SolutionsMolding Technology SolutionsBatesvilleTotal
End Market
  Plastics$229.5 $ $ $229.5 $464.5 $ $ $464.5 
  Automotive 56.3  56.3  105.9  105.9 
  Chemicals25.3   25.3 49.5   49.5 
  Consumer goods 35.3  35.3  75.0  75.0 
Food and pharmaceuticals24.5   24.5 46.3   46.3 
  Custom molders 34.7  34.7  73.0  73.0 
Packaging 31.2  31.2